$16.90
Price
$193M
Market Cap
—
P/E Ratio
-1079.5
Forward P/E
$-7.60
EPS (TTM)
—
Dividend Yield
$69M
Cash
$396000
Total Debt
11M
Shares Out
$4.86
$17.40
52-Week Range
Institutional Ownership of Kazia Therapeutics
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| 50.0K | $704000 | $12.54 | +5.34% |
Trading Activity for Kazia Therapeutics
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q2 | |||||
| BUY | NEW | 50.0K | $704000 | $12.54 | |
Insider Trading for Kazia Therapeutics
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.